Catalyst Wire Dossier Catalyst Wire Dossier

Nebicapone

nebicapone · Bial - Portela C S.A.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Nebicapone, covering 2017-04-06 to 2017-04-06. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Tolerability of Nebicapone in Parkinson's Disease Patients With "Wearingoff" Phenomenon [Phase 2]

See pricing